Since mRNA levels of the NFkB subunit RELB are elevated in basal-type breast cancer cells (Figure 5B), NFkB signals in those cells can also be blocked with shRNA targeting the RELB gene. The gene discussed is NFKB1; the disease is breast carcinoma.